MRK Forum Topics
- All Comments on MRK
- General Discussion on MRK
- Merck/Schering-Plough's Heart Drug Couldn't Have Done Worse [view article]
- Dow 30 Performance Since 7/15 [view article]
- Investing in Dividend Paying Companies [view article]
- HPC Vaccine Inspires Yellow Health Journalism [view article]
- Clarifying the Vytorin Situation: Three Key Questions [view article]
- Just What the Doctor Ordered: Comparing the Pharma ETFs [view article]
- This Week's Key Earnings Reports [view article]
- Tuesday Options Update: MRK, SNDK, TXN, TAP, GTXI, SPF, BRCD, XLF [view article]
- Wall Street Breakfast: Must-Know News [view article]
- Roche's Genentech Offer Sends Ripples Through Biotech [view article]
- Monday Options Outlook: SGP, MRK, AZN, AMGN, CELG, BBH, BAC, KRE, XLF [view article]
- The Top Dividend Paying ETFs and Stocks [view article]
Recent MRK Articles
- Dow 30 Performance Since 7/15
- Just What the Doctor Ordered: Comparing the Pharma ETFs
- Did Merck's Sex and the City Strategy Work?
- Merck/Schering-Plough's Heart Drug Couldn't Have Done Worse
- Clarifying the Vytorin Situation: Three Key Questions
- Tuesday Options Update: MRK, SNDK, TXN, TAP, GTXI, SPF, BRCD, XLF
- Wall Street Breakfast: Must-Know News
- Roche's Genentech Offer Sends Ripples Through Biotech
- HPC Vaccine Inspires Yellow Health Journalism
- Monday Options Outlook: SGP, MRK, AZN, AMGN, CELG, BBH, BAC, KRE, XLF
- Full List of Articles »
loading ...
Ten Companies Involved in Treating Asthma [view article]
Alvesco, ciclesonide is marketed by Sepracor, not Sanofi-Aventis ReplyWall Street Breakfast: Must-Know News [view article]
eudaimonia ReplySchweitzer
Wall Street Breakfast: Must-Know News [view article]
Always an early morning "oughta" read. ReplyTiedeman
Fast Money Recap, 3/27/08: Oracle a False Profit [view article]
People who doubt Oracle have been wrong time and again... ReplyFast Money Recap, 3/27/08: Oracle a False Profit [view article]
i love that show....only thing i try to watch on cnbc. i didn't like that there were 2 Najarian's, one's enough. they should bring back "pretty boy". Karen is so hot, i would be her biatch in a minute :p ReplyBig Pharma Power Shift: CFOs Have the Mojo Now [view article]
I wonder how long it will be before some rationalization starts to appear in the domestic market for drugs. Americans pay more for drugs than other countries, mostly because the drug distribution system isn't rationalized in the US. Large drug plan administrators, like Caremark, purchase drugs at steep discounts to what local drug stores can. They mandate the use of generics in some cases. They prevent prescriptions with interaction problems. They maintain highly automated and efficient pharmacies that send out drugs by mail or UPS.Because the US doesn't have a national health plan, the distribution scene is a hodge-podge of small pharmacies, regional chains, and national chains. In turn, HMOs, employers, unions, and other groups use pharmacy benefit managers in which formularies (allowed drugs) are unique and charges vary according to the membership of the plan. Customers usually get the first prescription at a local pharmacy and subsequent prescriptions by mail order from the plan.
A national prescription drug plan would greatly reduce costs and inefficiencies. The problem is that this would also decimate the pharmacy industry in the US, at least the small pharmacies. It would also create a problem as to how to distribute the business between drug plan administrators. However, the savings to the general public would be substantial.
The fact is that large-scale rationalization of this industry is on the way as baby-boomers start buying drugs in large quantities for their various ailments.
Rationalization equals declining margins. Enter the accountants. Reply
Wall Street Breakfast: Must-Know News [view article]
Aloha! Replyhy
Wall Street Breakfast: Must-Know News [view article]
Afreshup - Here's another - 'Swogeet' - from the midwest: means, 'Lets go eat!' ReplyWall Street Breakfast: Must-Know News [view article]
GregoryY - That's funny... since we are throwing cultural words around ... "jeetyet" translation :"Did you eat yet" in Southern circles... Reply
Wall Street Breakfast: Must-Know News [view article]
And if I'm not an American? Am I allowed to throw a word or two of another language into my remarks? You can't be much of an English speaker either, Sigler, if you are thrown by the expressions "Mazel tov" and "Shalom." One final point: Check the Bio of Eli Hoffman. You will discover he's Israeli. ReplyWall Street Breakfast: Must-Know News [view article]
If you're an American, SPEAK ENGLISH! ReplyWall Street Breakfast: Must-Know News [view article]
Shalom User 168657!!! ReplyWall Street Breakfast: Must-Know News [view article]
Mozel Tov Eli!!! ReplyBig Pharma Power Shift: CFOs Have the Mojo Now [view article]
The finance role should not be restricted keeping score, however in an increasingly complex financial system it is important that finance first masters the 'new basics' of complex financial products, systemic exchange rate changes and risk (both internal and macro).Once these are covered, I feel they should be a team member (not leader) in working on cost reduction and more importantly assisting the process of drug development by providing useful financial tools lower in the pyramid (examples: aligned budgeting and headcount systems etc).
IMHO the major boardroom opportunity is not in finance as addressed in the Ernst & Young report but in human resources. The metamorphosis most needed, not just in the boardroom but at every level in drug companies, is to change HR from just 'keeper of the rules/rewards' to engaged team player who understands the business, nurtures talent, enables change, benchmarks BioTechs, slaughters sacred cows, manages/rewards/retain... a global talent pool and most importantly translates new company strategy into CHANGES in HR systems that support a common goal.
As Big Pharma attempts to change gear into something more efficient, it would be foolish to try to do this without fundamentally changing the HR role. During a gearchange the only gear that stays unaltered is one that was neither engaged before or after.
The successful Big Pharma CEO will need a broader and more alligned role from all his functions. Cost cutting by putting finance on steroids won't deliver more successful products--Detroit is testament to that. Reply
Best and Worst Dow, S&P 500 Performers YTD [view article]
What Kranky says about WMT's meat is absolutely true. A couple of weeks ago, my neighbor bought $40 worth of ribeyes from WMT to celebrate a new job. They looked normal in the package, looked and smelled great on the grill, but I noticed something odd the moment I cut into one: there was no noticeable marbling - my steak cut like a thick slab of country ham. Unfortunately, due to all the saline WMT pumps into their meats (10% in most cases - check the meat label and see for yourself), my $10 ribeye tasted like a salty breakfast ham. I kid you not, it had the same consistency and taste of a freakin ham, even down to the little bubbles that form in a chopped and formed ham. I was disgusted, and will never buy WMT meat again. I am getting to the point where I won't buy WMT's groceries again, because as other posters here have pointed out, the larger grocery stores do actually tend to have cheaper prices. Are they collaborating to make Wal-Mart's food department a thing of the past? I hope so - WMT is growing too large for comfort. Reply